217 results
Page 7 of 11
8-K
EX-99.1
5zomrb6
2 Jul 09
Discovery Labs Reports on Surfaxin End of Review Meeting with FDA
12:00am
8-K
EX-99.1
dd9uao2j5h kq
12 May 09
Other Events
12:00am
8-K
EX-99.1
0vo8kd9 qokg6h
8 May 09
Discovery Labs to Raise $11.3 Million in Registered Direct Offering
12:00am
424B5
2qil2k5 o6
8 May 09
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
9l1 0b4xdd8uhppd0
29 Apr 09
Discovery Labs Reports First Quarter 2009 Financial Results
12:00am
8-K
EX-99.1
aerlzb9cyeims9el
24 Apr 09
Discovery Labs Receives Complete Response from FDA
12:00am
424B3
a17bqijbznjhcv9j8
9 Apr 09
Prospectus supplement
12:00am
8-K
EX-99.1
0mw5bka lz
13 Mar 09
Results of Operations and Financial Condition
12:00am
D
mr9uyd1ad
22 Dec 08
Exempt offering of security
12:00am
8-K
EX-99.1
61d07 o2poh
15 Dec 08
Discovery Labs Secures $25 Million Committed Equity Financing Facility
12:00am
8-K
EX-99.1
ax0s6dqanbeg
10 Nov 08
Discovery Labs Reports Third Quarter 2008 Financial Results
12:00am
8-K
EX-99.2
idbc9tkk3kukgh8mtnng
10 Nov 08
Discovery Labs Reports Third Quarter 2008 Financial Results
12:00am
8-K
EX-99.1
agu3 w1dr3x7dnq5gtg
22 Oct 08
Discovery Labs Submits Complete Response to May 2008 FDA Approvable Letter for SurfaxinÃ’ for RDS
12:00am
8-K
EX-99.1
7h801sf8j5o0drlj
24 Sep 08
Discovery Labs Reports Technical Achievements Towards Gaining
12:00am